Randomized clinical trial of the effect of applying ointment to surgical wounds before occlusive dressing

British Journal of Surgery

Volumn 93, Issue 8, 2006, Pages 937-943

  Dixon, A J ^a,b,d   Dixon, M P ^b   Dixon, J B ^c  

^a Skin Alert Skin Cancer Clinics   (Australia)

^b Skincanceronly   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d Skincanceronly   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOXACILLIN; LACRI LUBE; PARAFFIN; PSEUDOMONIC ACID;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; OINTMENT; OUTCOME ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTECTIVE CLOTHING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCAR; SKIN DISEASE; SURGICAL WOUND; SUTURE REMOVAL; TREATMENT RESPONSE; WOUND DEHISCENCE; WOUND HEMORRHAGE; WOUND INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUPIROCIN; OCCLUSIVE DRESSINGS; OINTMENTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WOUND HEALING;

EID: 33747079027     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5400     Document Type: Article

References (28)

1. Eedy DJ, Breathnach SM, Walker NPJ. Surgical Dermatology. Blackwell Science: Oxford, 1996.
2. Cho CY, Lo JS. Dressing the part. Dermatol Clin 1998; 16: 25-47.
3. Spann CT, Tutrone WD, Weinberg JM, Scheinfeld N, Deleo VA. Topical antibacterial agents for wound care: a primer. Dermatol Surg 2003; 29: 620-626.
4. Brown M, Johnson TM. Antibiotic prophylaxis in dermatologic surgery: updated guidelines. Counterpoint. Dermatol Surg 2005; 31: 91-93.
5. Futoryan T, Grande D. Postoperative wound infection rates in dermatologic surgery. Dermatol Surg 1995; 21: 509-514.
6. Angelini GD, Butchart EG, Armistead SH, Breckenridge IM. Comparative study of leg wound skin closure in coronary artery bypass graft operations. Thorax 1984; 39: 942-945.
7. Chang JK, Calligaro KD, Ryan S, Runyan D, Dougherty MJ, Stern JJ. Risk factors associated with infection of lower extremity revascularization: analysis of 365 procedures performed at a teaching hospital. Ann Vasc Surg 2003; 17: 91-96.
8. Corder AP, Schache DJ, Farquharson SM, Tristram S. Wound infection following high saphenous ligation. A trial comparing two skin closure techniques: subcuticular polyglycolic acid and interrupted monofilament nylon mattress sutures. J R Coll Surg Edinb 1991; 36: 100-102.
9. Watcher MA, Wheeland RG. The role of topical agents in the healing of full-thickness wounds. J Dermatol Surg Oncol 1989; 15: 1188-1195.
10. Molan PC. The potential of honey to promote oral wellness. Gen Dent 2001; 49: 584-589.
11. Vitasa BC, Taylor HR, Strickland PT, Rosenthal FS, West S, Abbey H et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990; 65: 2811-2817.
12. Czarnecki DB, Nash CG, Bohl TG. The use of mupirocin before skin surgery. Int J Dermatol 1991; 30: 218-219.
13. Villiger JW, Robertson WD, Kanji K, Ah Chan M, Fetherston J, Hague IK et al. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice. Curr Med Res Opin 1986; 10: 339-345.
14. Czarnecki D, Meehan C, Nash C. Prevention of post-excisional wound infections: a comparison of oral cephalexin with topical mupirocin and topical cetrimide-chlorhexidine cream. Int J Dermatol 1992; 31: 359-360.
15. Gisby J, Bryant J. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Antimicrob Agents Chemother 2000; 44: 255-260.
16. Perez-Roth E, Claverie-Martin F, Villar J, Mendez-Alvarez S. Multiplex PCR for simultaneous identification of Staphylococcus aureus and detection of methicillin and mupirocin resistance. J Clin Microbiol 2001; 39: 4037-4041.
17. Norazah A, Koh YT, Ghani Kamel A, Alias R, Lim VK. Mupirocin resistance among Malaysian isolates of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2001; 17: 411-414.
18. Cimochowski GE, Harostock MD, Brown R, Bernardi M, Alonzo N, Coyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 2001; 71: 1572-1578; discussion 1578-1579.
19. Semret M, Miller MA. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Infect Control Hosp Epidemiol 2001; 22: 578-580.
20. Thomas DW, Hill CM, Lewis MA, Stephens P, Walker R, Von Der Weth A. Randomized clinical trial of the effect of semi-occlusive dressings on the microflora and clinical outcome of acute facial wounds. Wound Repair Regen 2000; 8: 258-263.
21. Eaglstein WH, Sullivan TP, Giordano PA, Miskin BM. A liquid adhesive bandage for the treatment of minor cuts and abrasions. Dermatol Surg 2002; 28: 263-267.
22. Eaglstein WH, Davis SC, Mehle AL, Mertz PM. Optimal use of an occlusive dressing to enhance healing. Effect of delayed application and early removal on wound healing. Arch Dermatol 1988; 124: 392-395.
23. Nemeth AJ, Eaglstein WH, Taylor JR, Peerson LJ, Falanga V. Faster healing and less pain in skin biopsy sites treated with an occlusive dressing. Arch Dermatol 1991; 127: 1679-1683.
24. Mertz PM, Marshall DA, Eaglstein WH. Occlusive wound dressings to prevent bacterial invasion and wound infection. J Am Acad Dermatol 1985; 12: 662-668.
25. Harris B, Cai JP, Falanga V, Mertz P, Chin YH, Eaglstein W. The effects of occlusive dressings on the recruitment of mononuclear cells by endothelial binding into acute wounds. J Dermatol Surg Oncol 1992; 18: 279-283.
26. Kannon GA, Garrett AB. Moist wound healing with occlusive dressings. A clinical review. Dermatol Surg 1995; 21: 583-590.
27. Maragh SL, Otley CC, Roenigk RK, Phillips PK. Antibiotic prophylaxis in dermatologic surgery: updated guidelines. Dermatol Surg 2005; 31: 83-91.
28. Penington AJ, Mallucci P. Closure of elective skin defects in the leg with a fasciocutaneous V-Y island flap. Br J Plast Surg 1999; 52: 458-461.